What is Retatrutide?
A plain-English, research-use-only guide to Retatrutide: what it is, its research-use status, and how to tell a verified source from a risky one.
- US vendors carry it
- 80
US vendors carry it
- Top certificate score
- 9.5/10
Top certificate score
What Retatrutide is
Retatrutide is an investigational triple agonist, acting on the GLP-1, GIP, and glucagon receptors. It is one of the newer GLP-1-class compounds to appear widely in the research-peptide market.
Research-use status
Retatrutide is investigational and is not an approved medication. This guide does not summarise effects or trial results. Material sold by peptide vendors is sold for laboratory research use only.
This describes research-use status only. It is not medical advice and says nothing about effects, uses or dosing. Retatrutide is sold for laboratory research use only.
How to find a verified Retatrutide source
Because retatrutide is newer, quality varies, and the cheapest and priciest per-mg prices we recorded differ by a wide margin. Identity confirmation on a batch-matched COA is especially important for a compound this new to the market.
Compare 80 US Retatrutide sources
See every vendor ordered by certificate score, then vendor score; Zeptix Labs is listed first in our 2026 audit.
Retatrutide: Frequently Asked Questions
Is retatrutide approved?
No. Retatrutide is an investigational compound still in clinical development. Material sold by peptide vendors is research-grade, for laboratory use only.